CBD's Therapeutic Potential for Autism Spectrum Disorder
A comprehensive review finds CBD shows promise for treating core symptoms and comorbidities of autism through its interaction with the endocannabinoid system, gut-brain axis modulation, and multi-target pharmacological profile, with a favorable safety profile.
Quick Facts
What This Study Found
CBD interacts with the endocannabinoid system, which plays crucial roles in social and behavioral processing and neuronal development relevant to ASD. Preliminary clinical trial data indicate CBD may modulate specific ASD symptoms and comorbidities. Emerging evidence suggests CBD may also influence the gut microbiota, relevant to gut-brain communication in ASD.
Key Numbers
CBD described as safe with low side effects; multi-target pharmacological profile; evidence from preclinical models and preliminary clinical trials
How They Did This
Review of preclinical and clinical evidence for CBD in ASD, examining endocannabinoid system involvement, clinical trial results, gut microbiome interactions, and safety data.
Why This Research Matters
ASD has very limited effective pharmacological interventions. CBD's multi-target profile and safety record make it a candidate for addressing both core symptoms and the many comorbidities (anxiety, sleep problems, irritability) that significantly affect quality of life for individuals with ASD.
The Bigger Picture
The endocannabinoid system's role in social behavior and brain development provides a theoretical foundation for why CBD might help in ASD. The gut-brain axis connection is a newer and intriguing dimension of this research.
What This Study Doesn't Tell Us
Most evidence is preclinical. Clinical trials have been small and preliminary. ASD is highly heterogeneous, making treatment response unpredictable. Long-term safety in developing brains needs more study.
Questions This Raises
- ?Which ASD subpopulations are most likely to benefit from CBD?
- ?Could CBD's gut microbiome effects contribute to behavioral improvements in ASD?
Trust & Context
- Key Stat:
- CBD interacts with the endocannabinoid system, which regulates social behavior and brain development relevant to ASD
- Evidence Grade:
- Review of mostly preclinical evidence with preliminary clinical findings. Theoretical framework is strong but clinical evidence remains early-stage.
- Study Age:
- Published in 2024.
- Original Title:
- Therapeutic potential of CBD in Autism Spectrum Disorder.
- Published In:
- International review of neurobiology, 177, 149-203 (2024)
- Authors:
- Pedrazzi, João F C(4), Hassib, Lucas, Ferreira, Frederico R(2), Hallak, Jaime C, Del-Bel, Elaine, Crippa, José A
- Database ID:
- RTHC-05613
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Could CBD help with autism?
Preliminary evidence is promising. CBD's interaction with the endocannabinoid system and its effects on anxiety, sleep, and the gut-brain axis are all relevant to ASD, but large clinical trials are still needed.
Is CBD safe for people with autism?
CBD is generally described as safe with low side effects, but long-term safety data specifically in ASD populations is limited, especially for children.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-05613APA
Pedrazzi, João F C; Hassib, Lucas; Ferreira, Frederico R; Hallak, Jaime C; Del-Bel, Elaine; Crippa, José A. (2024). Therapeutic potential of CBD in Autism Spectrum Disorder.. International review of neurobiology, 177, 149-203. https://doi.org/10.1016/bs.irn.2024.05.002
MLA
Pedrazzi, João F C, et al. "Therapeutic potential of CBD in Autism Spectrum Disorder.." International review of neurobiology, 2024. https://doi.org/10.1016/bs.irn.2024.05.002
RethinkTHC
RethinkTHC Research Database. "Therapeutic potential of CBD in Autism Spectrum Disorder." RTHC-05613. Retrieved from https://rethinkthc.com/research/pedrazzi-2024-therapeutic-potential-of-cbd
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.